Artiva Biotherapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 9.85 M | $28.28 M | 0.00% | 40.42% |
| 5AM VENTURE MANAGEMENT, LLC | 11/14/2025 | 2.35 M | $6.75 M | 0.00% | 9.65% |
| VR ADVISER, LLC | 11/14/2025 | 1.61 M | $4.62 M | 0.00% | 6.60% |
| VENBIO PARTNERS LLC | 11/14/2025 | 1.15 M | $3.30 M | 0.00% | 4.71% |
| CITADEL ADVISORS LLC | 11/14/2025 | 798.40 K | $2.29 M | 419.32% | 3.28% |
| FRANKLIN RESOURCES INC | 11/13/2025 | 520.33 K | $1.49 M | 0.00% | 2.13% |
| BLACKROCK, INC. | 11/12/2025 | 294.42 K | $844.99 K | -39.39% | 1.21% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 262.16 K | $752.40 K | -19.85% | 1.08% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 194.11 K | $557.09 K | 0.00% | 0.80% |
| VANGUARD GROUP INC | 11/07/2025 | 159.12 K | $456.67 K | -31.70% | 0.65% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 118.55 K | $340.23 K | 14,463.51% | 0.49% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 110.90 K | $318.51 K | -30.27% | 0.45% |
| CITIGROUP INC | 11/10/2025 | 105.57 K | $303.00 K | 2,859.71% | 0.43% |
| ALYESKA INVESTMENT GROUP, L.P. | 11/17/2025 | 100.00 K | $287.00 K | 0.00% | 0.41% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 79.15 K | $227.15 K | 100.00% | 0.32% |
| STATE STREET CORP | 11/14/2025 | 59.82 K | $171.70 K | -4.85% | 0.25% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 49.78 K | $142.86 K | -57.82% | 0.20% |
| XTX TOPCO LTD | 11/14/2025 | 47.97 K | $137.68 K | 100.00% | 0.20% |
| MORGAN STANLEY | 11/14/2025 | 42.83 K | $122.92 K | -7.39% | 0.18% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 11/13/2025 | 39.13 K | $112.31 K | 100.00% | 0.16% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2025 | 35.00 K | $100.45 K | 0.00% | 0.14% |
| HRT FINANCIAL LP | 11/14/2025 | 26.95 K | $77.00 K | -65.29% | 0.11% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2025 | 25.55 K | $73.33 K | -33.96% | 0.10% |
| UBS GROUP AG | 11/13/2025 | 21.14 K | $60.68 K | 533.59% | 0.09% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 20.36 K | $58.45 K | -4.71% | 0.08% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 16.15 K | $46.34 K | 225.83% | 0.07% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 11/14/2025 | 14.30 K | $41.05 K | 100.00% | 0.06% |
| BARCLAYS PLC | 11/12/2025 | 12.70 K | $36.44 K | 566.11% | 0.05% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 9.98 K | $28.65 K | -1.16% | 0.04% |
| RUSSELL INVESTMENTS GROUP, LTD. | 11/13/2025 | 5.49 K | $15.76 K | 0.00% | 0.02% |
| FMR LLC | 11/13/2025 | 4.92 K | $14.12 K | -88.36% | 0.02% |
| CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 11/10/2025 | 4.28 K | $12.29 K | -12.51% | 0.02% |
| JPMORGAN CHASE & CO | 11/26/2025 | 4.00 K | $11.49 K | 362.66% | 0.02% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 1.70 K | $4.88 K | -17.64% | 0.01% |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 11/03/2025 | 944 | $2.71 K | 0.32% | 0.00% |
| ROYAL BANK OF CANADA | 11/14/2025 | 840 | $3.00 K | -25.00% | 0.00% |
| GF FUND MANAGEMENT CO. LTD. | 11/07/2025 | 510 | $1.46 K | -15.42% | 0.00% |
| MARK SHEPTOFF FINANCIAL PLANNING, LLC | 11/13/2025 | 400 | $1.15 K | 0.00% | 0.00% |
| EVERSOURCE WEALTH ADVISORS, LLC | 11/10/2025 | 159 | $456 | 100.00% | 0.00% |
| NORTHERN TRUST CORP | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| NISA INVESTMENT ADVISORS, LLC | 10/23/2025 | 0 | $0 | -100.00% | 0.00% |
| DEUTSCHE BANK AG\ | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
| MARSHALL WACE, LLP | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| GROUND SWELL CAPITAL, LLC | 11/06/2025 | 0 | $0 | -100.00% | 0.00% |
| ACUTA CAPITAL PARTNERS, LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| SQUAREPOINT OPS LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| SAMSARA BIOCAPITAL, LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| Y-INTERCEPT (HONG KONG) LTD | 10/31/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Artiva Biotherapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 53 institutional investors and hedge funds held shares of Artiva Biotherapeutics, Inc.. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 9.85 M
5AM Venture Management, LLC: 2.35 M
VR Adviser, LLC: 1.61 M
venBio Partners LLC: 1.15 M
CITADEL ADVISORS LLC: 798,397
FRANKLIN RESOURCES INC: 520,327
74.46% of Artiva Biotherapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 18.17 M shares in the last 24 months. This purchase volume represents approximately $68.60 M in transactions.